Dyckerhoff Stefan A sold 12,499 Astera Labs shares in 12 transactions on 2026-09-02, with prices ranging from $273.64 to $276.75 per share. The reported post-transaction holding was 3,309 shares, giving investors the specific remaining ownership figure tied to the insider transaction.
Key Highlights
- The Astera Labs transactions took place on 2 September 2026.
- Sale prices ranged from $273.64 to $276.75 per share.
- The sales consisted of 12 separate transactions marked with code S.
Dyckerhoff Stefan A sold 12,499 shares of Astera Labs, Inc. leaving 3,309 shares in his reported holding. The transactions were completed on 2 September 2026. Astera Labs identifies Dyckerhoff as an insider.
12 Sales Covered the Reported Filing
The share sales were recorded across 12 separate transactions, each carrying SEC transaction code S. Prices ranged from $273.64 to $276.75 per share. The disclosed ownership figure after the transactions was 3,309 Astera Labs shares. The filing identifies the activity as sales of Astera Labs shares. The reported price range applies to the per-share prices recorded across the transactions. The ownership figure represents the position held after the sales.
FAQs
Q: How many Astera Labs shares did Dyckerhoff Stefan A sell?
A: Dyckerhoff Stefan A sold 12,499 Astera Labs shares. The Form 4 reports that these sales occurred in 12 separate transactions on 2 September 2026.
Q: How many Astera Labs shares did Dyckerhoff Stefan A still own?
A: The filing reported that Dyckerhoff Stefan A owned 3,309 Astera Labs shares after the transactions. This was the disclosed post-transaction ownership figure.
Q: What prices did Dyckerhoff Stefan A receive for the Astera Labs shares?
A: The Astera Labs shares were sold at prices ranging from $273.64 to $276.75 per share. The range covers the recorded transaction prices.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.